StockData
Vir Biotechnology, Inc. logo

Vir Biotechnology, Inc. (VIR) stock

VIRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3028% below fair value
$9.58−0.38 (-3.82%)

Close on Nov 16, 2026Market cap $1.62BP/E –Yield –

Vir Biotechnology EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Vir Biotechnology's EV/EBITDA was 1.1× on Apr 28, 2023, against 4.1× a year earlier.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2023Apr 28, 20231.1×+0.5
2022Dec 30, 20220.6×–

More Vir Biotechnology figures

See a number that looks wrong?